Living with a pulmonary arterial hypertension (PAH) diagnosis can be challenging, but there are treatment options available to help manage this condition. One such option is Flolan, a medication that works by dilating blood vessels in the lungs and improving blood flow. In this blog post, we'll explore the benefits of Flolan for patients and caregivers alike. From its mechanism of action to potential side effects, we've got you covered on everything you need to know about Flolan. So let's dive in!
Flolan, also known as epoprostenol sodium, is a medication that helps treat pulmonary arterial hypertension (PAH). This condition causes high blood pressure in the arteries of your lungs and can make it difficult for your heart to pump blood. Flolan works by dilating these constricted arteries, allowing for better blood flow.
The drug is administered through an IV directly into the bloodstream. Patients who use Flolan typically require continuous infusion therapy due to its short half-life. While this may seem daunting, many patients find that the benefits of Flolan outweigh any inconvenience its administration may cause.
Flolan, also known as epoprostenol sodium, is a medication that helps to dilate blood vessels in the lungs. This allows for improved blood flow and oxygenation in patients with pulmonary arterial hypertension (PAH) or related conditions.
One of the key benefits of Flolan is its ability to improve exercise tolerance and reduce symptoms such as shortness of breath and fatigue. Patients may be able to engage in physical activity more easily, improving their quality of life.
Another important benefit is Flolan's ability to prolong survival and improve hemodynamics (blood flow) in PAH patients. Studies have shown that treatment with Flolan can significantly increase 1-year survival rates compared to placebo.
In addition, Flolan may help prevent acute pulmonary hypertensive crises. These episodes can be life-threatening for PAH patients and require emergency medical intervention. By using Flolan regularly, patients may experience fewer crises or less severe episodes when they do occur.
As with any medication, Flolan can cause some side effects in patients. It's important to be aware of these potential side effects prior to starting treatment with Flolan.
One common side effect is pain at the injection site. This can occur due to the continuous infusion pump that delivers Flolan into your bloodstream. The pain may range from mild discomfort to severe pain and may require medical attention if it persists for a prolonged period.
Flolan is a medication that has proven to be a useful treatment for patients suffering from pulmonary arterial hypertension. It works by dilating the blood vessels in the lungs and improving blood flow, which can help reduce symptoms such as shortness of breath and fatigue.
It's important to note that while Flolan has been available for several years, new treatments continue to emerge. Veletri is one such alternative that may offer similar benefits with fewer side effects.
1.
Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk
2.
Year in Review: Multiple Myeloma
3.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
4.
Beyond What Is Visible in Myelofibrosis?
5.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
1.
Best Clinical Practices in Hematology
2.
The Growing Challenge of Haematological Malignancies in Older Adults
3.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
4.
Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends
5.
Geriatric Oncology and Treatment Sequencing: Evidence-Based Approaches for the Aging Cancer Population
1.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Symposium on Oncology, Cardiology and Critical Care Innovations
4.
International Conference on Cancer Nursing and Hematology Support
5.
International Conference on Clinical Medicine and Surgical Care
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation